Antitumor effect of novel anti‐podoplanin antibody NZ‐12 against malignant pleural mesothelioma in an orthotopic xenograft modelShinji Abe, Yasuhiko Nishioka, Yukinari Kato et al.|Cancer Science|2016Cited by 62
A multicenter, open-label, phase II trial of S-1 plus carboplatin in advanced non-small cell lung cancer patients with interstitial lung diseaseMasaki Hanibuchi, Yasuhiko Nishioka, Soji Kakiuchi et al.|Lung Cancer|2018Cited by 31
Analysis of acute exacerbation of interstitial lung disease associated with chemotherapy in patients with lung cancer: A feasibility of S-1Soji Kakiuchi, Yasuhiko Nishioka, Masaki Hanibuchi et al.|Respiratory Investigation|2016Cited by 27
Analysis of the Prognostic Factors of Extensive Disease Small-Cell Lung Cancer Patients in Tokushima University HospitalHirokazu Ogino, Yasuhiko Nishioka, Masaki Hanibuchi et al.|The Journal of Medical Investigation|2016Cited by 11
The clinical features of older patients with lung cancer in comparison with their younger counterpartsHirokazu Ogino, Yasuhiko Nishioka, Masaki Hanibuchi et al.|Respiratory Investigation|2018Cited by 6